Moreover, it warrants future efforts to further evaluate whether inhibiting DNA methylation and abrogating the interaction among PHF14, DNMT3B and DNA can be a potential strategy for targeting TGF-β-driven LAD progression and metastasis. The gene discussed is TGFB1; the disease is leukocyte adhesion deficiency.